Activation	O
of	O
the	O
Na(+	B:C0074785
)	I:C0074785
/H(+	I:C0074785
)	I:C0074785
exchanger	I:C0074785
in	O
isolated	O
cardiomyocytes	B:C0225828
through	O
β-	B:C1259929
Raf	I:C1259929
dependent	O
pathways	B:C1704259
.	O

Role	O
of	O
Thr	B:C0040005
(	I:C0040005
653	I:C0040005
)	I:C0040005
of	O
the	O
cytosolic	B:C1511625
tail	I:C1511625
.	O

The	O
mammalian	B:C0024660
Na(+	B:C1113671
)	I:C1113671
/H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
(	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
)	O
is	O
a	O
ubiquitous	O
plasma	B:C1179841
membrane	I:C1179841
protein	I:C1179841
that	O
is	O
a	O
key	O
regulator	B:C1655052
of	I:C1655052
intracellular	I:C1655052
pH	I:C1655052
in	O
isolated	O
cardiomyocytes	B:C0225828
.	O

A	O
500	O
amino	B:C1513110
acid	I:C1513110
membrane	I:C1513110
domain	I:C1513110
removes	O
protons	B:C0033727
and	O
is	O
regulated	O
by	O
a	O
315	O
amino	B:C0002520
acid	I:C0002520
cytosolic	B:C1511625
domain	I:C1511625
.	O

In	O
the	O
myocardium	B:C0027061
,	O
aberrant	O
regulation	B:C1327622
of	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
contributes	O
to	O
ischemia	B:C0035126
reperfusion	I:C0035126
damage	I:C0035126
and	O
to	O
heart	B:C1383860
hypertrophy	I:C1383860
.	O

We	O
examined	B:C0332128
mechanisms	O
of	O
regulation	B:C1327622
of	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
in	O
the	O
myocardium	B:C0027061
by	O
endothelin	B:C0079284
and	O
β-	B:C1259929
Raf.	I:C1259929
Endothelin	B:C0079284
stimulated	O
Na(	B:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
activity	O
and	O
activated	O
Erk	B:C3179234
-	I:C3179234
dependent	I:C3179234
pathways	I:C3179234
.	O

Inhibition	O
of	O
β-	B:C1259929
Raf	I:C1259929
reduced	O
Na(+	B:C1113671
)	I:C1113671
/H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
activity	O
and	O
Erk-	B:C3179234
pathway	I:C3179234
activation	O
.	O

We	O
demonstrated	O
that	O
myocardial	B:C0027061
β-	B:C1259929
Raf	I:C1259929
binds	O
to	O
the	O
C-	B:C1707271
terminal	I:C1707271
182	I:C1707271
amino	I:C1707271
acids	I:C1707271
of	O
the	O
NHE1	B:C1113671
protein	I:C1113671
and	O
that	O
β-	B:C1259929
Raf	I:C1259929
is	O
associated	O
with	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
in	O
intact	O
cardiomyocytes	B:C0225828
.	O

Na	B:C1113671
(+	I:C1113671
)/H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
was	O
phosphorylated	B:C0031715
in	B:C1515655
vivo	I:C1515655
and	O
the	O
protein	B:C1449702
kinase	I:C1449702
inhibitor	I:C1449702
sorafenib	B:C1516119
reduced	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
phosphorylation	B:C0031715
levels	O
.	O

Immunoprecipitates	B:C0301871
of	O
β-	B:C1259929
Raf	I:C1259929
from	O
cardiomyocytes	B:C0225828
phosphorylated	B:C0031715
the	O
C-	B:C1707271
terminal	I:C1707271
182	I:C1707271
amino	I:C1707271
acids	I:C1707271
of	O
Na(	B:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
and	O
mass	B:C0037813
spectrometry	I:C0037813
analysis	I:C0037813
showed	O
that	O
amino	B:C0002520
acid	I:C0002520
Thr	B:C0040005
(	I:C0040005
653	I:C0040005
)	I:C0040005
was	O
phosphorylated	B:C0031715
.	O

Mutation	B:C0026882
of	O
this	O
amino	B:C0002520
acid	I:C0002520
to	O
Ala	B:C0001898
resulted	O
in	O
defective	O
activity	O
while	O
mutation	B:C0026882
to	O
Asp	B:C0085845
restored	O
the	O
activity	O
.	O

The	O
results	B:C0456984
demonstrate	O
that	O
Thr	B:C0040005
(	I:C0040005
653	I:C0040005
)	I:C0040005
is	O
an	O
important	O
regulator	O
y	O
amino	B:C0002520
acid	I:C0002520
of	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
that	O
is	O
activated	O
through	O
β-	B:C1259929
Raf	I:C1259929
dependent	O
pathways	B:C1704259
by	O
phosphorylation	B:C0031715
either	O
directly	O
or	O
indirectly	O
by	O
β-	B:C1259929
Raf	I:C1259929
,	O
and	O
this	O
affects	O
Na	B:C1113671
(	I:C1113671
+	I:C1113671
)	I:C1113671
/	I:C1113671
H(+	I:C1113671
)	I:C1113671
exchanger	I:C1113671
isoform	I:C1113671
1	I:C1113671
activity	O
.	O

